{"id":244054,"title":"Summary: NACI supplemental statement on Recombinant influenza vaccines, CCDR 48(9) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T18:59:30.666000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-9-september-2022/summary-national-advisory-committee-immunization-naci-supplemental-statement-recombinant-influenza-vaccines.html?wbdisable=false","snippet":"Summary: NACI supplemental statement on Recombinant influenza vaccines, CCDR 48(9) - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and the workplace Immigration…","rawSnapshotUrl":"/api/snapshots/raw/244054","browseUrl":"https://replay.healtharchive.ca/job-1/20250418185930/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-9-september-2022/summary-national-advisory-committee-immunization-naci-supplemental-statement-recombinant-influenza-vaccines.html?wbdisable=false#ha_snapshot=244054","mimeType":"text/html","statusCode":200}